Ridgeworth Ceredex Mid Cap Fund Chance Of Distress
SAMVX Fund | USD 13.40 0.08 0.59% |
Ridgeworth |
Ridgeworth Ceredex Mid Cap Mutual Fund chance of distress Analysis
Ridgeworth Ceredex's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
More About Probability Of Bankruptcy | All Equity Analysis
Probability Of Bankruptcy | = | Normalized | | Z-Score |
Current Ridgeworth Ceredex Probability Of Bankruptcy | Less than 20% |
Most of Ridgeworth Ceredex's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ridgeworth Ceredex Mid Cap is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of Ridgeworth Ceredex probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Ridgeworth Ceredex odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Ridgeworth Ceredex Mid Cap financial health.
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
Competition |
Based on the latest financial disclosure, Ridgeworth Ceredex Mid Cap has a Probability Of Bankruptcy of 20.0%. This is much higher than that of the Virtus family and significantly higher than that of the Mid-Cap Value category. The probability of bankruptcy for all United States funds is notably lower than that of the firm.
Ridgeworth Probability Of Bankruptcy Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ridgeworth Ceredex's direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the mutual funds which would be a good addition to a portfolio. Peer analysis of Ridgeworth Ceredex could also be used in its relative valuation, which is a method of valuing Ridgeworth Ceredex by comparing valuation metrics of similar companies.Ridgeworth Ceredex is currently under evaluation in probability of bankruptcy among similar funds.
Ridgeworth Fundamentals
Price To Earning | 19.31 X | |||
Price To Book | 1.96 X | |||
Price To Sales | 1.41 X | |||
Total Asset | 183.03 M | |||
Annual Yield | 0.01 % | |||
Year To Date Return | 15.68 % | |||
One Year Return | 24.54 % | |||
Three Year Return | 4.03 % | |||
Five Year Return | 7.85 % | |||
Ten Year Return | 8.63 % | |||
Net Asset | 2.38 B | |||
Cash Position Weight | 2.47 % | |||
Equity Positions Weight | 97.53 % |
About Ridgeworth Ceredex Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ridgeworth Ceredex Mid Cap's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ridgeworth Ceredex using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ridgeworth Ceredex Mid Cap based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Ridgeworth Mutual Fund
Ridgeworth Ceredex financial ratios help investors to determine whether Ridgeworth Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ridgeworth with respect to the benefits of owning Ridgeworth Ceredex security.
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Bonds Directory Find actively traded corporate debentures issued by US companies |